Study objectives: To evaluate the outcomes of a nurse- led, HCV education, testing, and linkage-to-care program located at the BCCfE’S Hope to Health (H2H) supervised consumption site in the Downtown Eastside of Vancouver.
STUDIES MENU
Activities
Offer rapid HCV testing in a low-barrier supervised consumption site to all clients
conduct interviewer administered questionnaire at baseline and 6-month follow up to assess self reported substance use patterns, engagement with health care, and harm reduction access
characterize health care experiences and outcomes for clients of nurse- led intervention embedded within a community setting frequented by people who use drugs
Start Date
November 2021
Funding Organization (2021-2022)
Scroll to Top
CLICK FOR GP-41 DISCONTINUATION NOTICE
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025